0.3910
+0.0010
+(0.26%)
As of 8:01:00 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
186,964.7500
186,964.7500
151,517
103,187
102,962
Cost of Revenue
136,359.3410
136,359.3410
114,119
76,780
76,264
Gross Profit
50,605.4090
50,605.4090
37,399
26,407
26,698
Operating Expense
38,819.4840
38,819.4840
27,376
20,721
17,818
Operating Income
11,785.9250
11,785.9250
10,023
5,686
8,880
Net Non Operating Interest Income Expense
-2,370.3010
-2,370.3010
-950
-576
-1,095
Pretax Income
7,530.3260
7,530.3260
9,076
5,110
7,500
Tax Provision
3,955.2320
3,955.2320
1,959
1,142
1,766
Net Income Common Stockholders
3,575.0940
3,575.0940
7,117
3,968
5,734
Diluted NI Available to Com Stockholders
3,575.0940
3,575.0940
7,117
3,968
5,734
Basic EPS
0.15
--
0.30
0.17
0.24
Diluted EPS
0.15
--
0.30
0.17
0.24
Basic Average Shares
23,833.9600
--
23,723.3330
24,000
24,000
Diluted Average Shares
24,420
--
23,723.3330
24,000
24,000
Total Operating Income as Reported
11,788.7090
11,788.7090
10,026
5,686
8,880
Total Expenses
175,178.8250
175,178.8250
141,495
97,501
94,082
Net Income from Continuing & Discontinued Operation
3,575.0940
3,575.0940
7,117
3,968
5,734
Normalized Income
3,572.9217
3,572.9217
7,113.8634
4,315.1029
5,951.8920
Interest Income
72.8890
72.8890
1,008
432
265
Interest Expense
2,443.1900
2,443.1900
1,958
1,008
1,360
Net Interest Income
-2,370.3010
-2,370.3010
-950
-576
-1,095
EBIT
9,973.5160
9,973.5160
11,034
6,118
8,860
EBITDA
18,623.3030
18,623.3030
12,215
6,960
9,688
Reconciled Cost of Revenue
136,359.3410
136,359.3410
114,119
76,780
76,264
Reconciled Depreciation
8,647
8,647
1,178
842
828
Net Income from Continuing Operation Net Minority Interest
3,575.0940
3,575.0940
7,117
3,968
5,734
Total Unusual Items Excluding Goodwill
2.7850
2.7850
4
-447
-285
Total Unusual Items
2.7850
2.7850
4
-447
-285
Normalized EBITDA
18,620.5180
18,620.5180
12,211
7,407
9,973
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
0.6127
0.6127
0.8634
-99.8971
-67.1080
12/31/2020 - 12/30/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AKUP.BE Akzo Nobel NV
16.40
-4.09%
AMC.SG Albemarle Corp
48.47
+0.11%
CYCLE.ST Cyclezyme AB
16.20
-4.14%
CSNVY Corbion N.V.
18.75
0.00%
GALAXYSURF.BO Galaxy Surfactants Limited
2,185.90
+4.86%
4202.T Daicel Corporation
1,143.50
-2.60%
AMC.DE Albemarle Corporation
48.27
-2.72%
NZYM.VI Novonesis A/S
53.06
+0.91%
MGS.MI Magis S.p.A.
13.90
+2.21%
1COV.F Covestro AG
58.26
+0.03%